| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KIMMR
|
13.00 | 3.1B | 4.55 | 0.62 | 1.89 | -1.7% | 29.4% | 76 | 31 | 38.77 | +136.8% | 70 | 0.47 |
|
MGROS
|
516.00 | 91.9B | 13.27 | 1.04 | 1.79 | 6.8% | 39.0% | 66 | 35 | 1,078.36 | +81.7% | 68 | 0.41 |
|
BIZIM
|
23.78 | 1.9B | — | 14.64 | 0.68 | 1.1% | 38.6% | 54 | 47 | 71.34 | +102.0% | 41 | 15.00 |
|
SOKM
|
58.00 | 34.4B | — | 0.90 | 2.23 | -10.6% | 34.7% | 51 | 27 | 156.40 | +86.5% | 58 | 0.41 |
|
BIMAS
|
412.75 | 978.9B | 44.89 | 5.18 | 14.42 | 5.4% | 37.8% | 41 | 16 | 169.42 | -44.2% | 73 | 0.31 |
|
GMTAS
|
44.72 | 13.4B | — | 3.09 | 33.88 | 9.7% | 43.0% | 35 | 16 | 21.17 | -36.3% | 86 | 0.01 |
|
CRFSA
|
305.00 | 39.0B | — | 10.91 | 6.06 | -7.4% | 36.8% | 18 | 22 | 177.82 | -21.3% | 33 | 3.67 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.